Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer

Adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metastatic high-risk prostate cancer

Welcome to APCCC 2021

IMpower010: A Phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC

ESMO 2021 Roundup

Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple myeloma

OncoAlert and ecancer - ESMO 2021 Day 5

Managing patients with EGFR exon 20 ins in NSCLC and EGFR TKI toxicity

New MM patients with high levels of circulating tumour cells distinguished by increased bone marrow plasma cell proliferation

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma

PARP inhibitors in prostate cancer: Case based testing and clinical decisions

KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with CRC harboring a KRASG12C mutation